Pallister-Hall syndrome (PHS) is an autosomal dominant disorder caused by truncating mutations in the middle third of the GLI3 gene. These mutations produce a constitutive transcriptional repressor that inappropriately suppresses Hedgehog target genes, causing a distinct phenotype from the allelic disorder Greig cephalopolysyndactyly syndrome. PHS is characterized by hypothalamic hamartoma, postaxial or central polydactyly, bifid epiglottis, anal atresia, and variable other malformations. Severity ranges from lethal neonatal forms to mild adult presentations.
Ask a research question about Pallister-Hall Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
name: Pallister-Hall Syndrome
creation_date: '2026-02-13T00:31:42Z'
category: Mendelian
description: >
Pallister-Hall syndrome (PHS) is an autosomal dominant disorder caused by
truncating mutations in the middle third of the GLI3 gene. These mutations
produce a constitutive transcriptional repressor that inappropriately suppresses
Hedgehog target genes, causing a distinct phenotype from the allelic disorder
Greig cephalopolysyndactyly syndrome. PHS is characterized by hypothalamic
hamartoma, postaxial or central polydactyly, bifid epiglottis, anal atresia,
and variable other malformations. Severity ranges from lethal neonatal forms
to mild adult presentations.
disease_term:
preferred_term: Pallister-Hall syndrome
term:
id: MONDO:0007804
label: Pallister-Hall syndrome
parents:
- Limb Development Disorders
inheritance:
- name: Autosomal Dominant
description: >
Autosomal dominant with variable expressivity. Unlike GCPS which
results from GLI3 haploinsufficiency, PHS is caused specifically by
frameshift/nonsense mutations in the middle third of GLI3 that
produce a truncated constitutive repressor protein.
evidence:
- reference: PMID:15739154
reference_title: "Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations."
supports: SUPPORT
snippet: "GLI3 mutations that predict a truncated functional repressor protein cause PHS and that functional haploinsufficiency of GLI3 causes GCPS"
explanation: "Distinct pathogenic mechanism from GCPS: constitutive repressor rather than haploinsufficiency."
classifications:
isds_skeletal_category:
- classification_value: polydactyly_syndactyly_triphalangism
notes: >-
ISDS Nosology and Classification of Genetic Skeletal Disorders, 2019 revision
(Mortier et al., PMID:31633310), Table 1 group 41
"Polydactyly-Syndactyly-Triphalangism group"; listed as "Pallister-Hall syndrome".
prevalence:
- population: GLI3 mutation-positive GCPS/PHS diagnostic cohort
percentage: 27.6%
notes: >-
Population prevalence for Pallister-Hall syndrome is not well defined, but a
large GLI3 cohort reported 21 PHS cases among 76 total GLI3 syndrome cases.
evidence:
- reference: PMID:24736735
reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Here we report on the molecular and clinical study of 76 cases from 55 families with either a GLI3 mutation (49 GCPS and 21 PHS), or a large deletion encompassing the GLI3 gene (6 GCPS cases)."
explanation: This large GLI3 cohort shows that 21 of 76 mutation-positive GCPS/PHS cases were Pallister-Hall syndrome, corresponding to 27.6%.
- reference: PMID:29106787
reference_title: "Familial Pallister-Hall in adulthood"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "This rare syndrome has not had prevalence defined, however."
explanation: This adult case report explicitly notes that population prevalence for Pallister-Hall syndrome has not been defined.
pathophysiology:
- name: GLI3 Constitutive Repressor from Truncating Mutations
description: >
Truncating mutations in the middle third of GLI3 (ORF nt 1998-3481)
produce a protein that retains the N-terminal zinc finger DNA-binding
domain and repressor domain but lacks the C-terminal transactivation
domain. This truncated protein functions as a constitutive repressor
of Hedgehog target genes, independent of Hedgehog signaling input.
biological_processes:
- preferred_term: Hedgehog Signaling Pathway
term:
id: GO:0007224
label: smoothened signaling pathway
evidence:
- reference: PMID:15739154
reference_title: "Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations."
supports: SUPPORT
snippet: "In contrast, PHS was caused only by frameshift/nonsense and splicing mutations"
explanation: "Only truncating mutations cause PHS, supporting the constitutive repressor model."
- reference: PMID:15739154
reference_title: "Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations."
supports: SUPPORT
snippet: "among the frameshift/nonsense mutations, there was a clear genotype-phenotype correlation"
explanation: "Positional specificity of truncating mutations determines GCPS vs PHS phenotype."
- reference: PMID:10375510
reference_title: "Gli proteins encode context-dependent positive and negative functions: implications for development and disease."
supports: SUPPORT
snippet: "C-terminal sequences are required for positive inducing activity"
explanation: "Loss of C-terminal transactivation domain explains why middle-third truncations produce a constitutive repressor."
- reference: PMID:10693759
reference_title: "Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb."
supports: SUPPORT
snippet: "The high relative abundance and potency of Gli3 repressor suggest specialization of Gli3 and its products for negative Hedgehog pathway regulation"
explanation: "GLI3 is specialized for repressor function, explaining why truncated repressor proteins cause disease."
- name: Hypothalamic Development Disruption
description: >
Constitutive GLI3 repressor activity inappropriately silences Hedgehog
target genes required for hypothalamic development, leading to
hypothalamic hamartoma formation. This can cause precocious puberty
through ectopic GnRH secretion or gelastic seizures.
downstream:
- target: Hypothalamic-Pituitary Axis Disruption
description: Hypothalamic hamartoma formation disrupts pituitary signaling, leading to endocrine insufficiency including adrenal insufficiency.
evidence:
- reference: PMID:10375510
reference_title: "Gli proteins encode context-dependent positive and negative functions: implications for development and disease."
supports: SUPPORT
snippet: "provide a molecular basis for the human Polydactyly type A and Pallister-Hall Syndrome phenotypes, derived from the deregulated production of C-terminally truncated GLI3 proteins"
explanation: "Truncated GLI3 repressor disrupts multiple developmental programs including hypothalamic development."
- reference: PMID:20301638
reference_title: "GLI3-Related Pallister-Hall Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."
explanation: "Hypothalamic hamartoma disrupts hypothalamic-pituitary signaling, causing pituitary insufficiency and potentially fatal adrenal insufficiency."
- name: Posterior Limb Patterning Disruption
description: >
Constitutive GLI3 repressor activity disrupts Hedgehog-dependent limb
patterning, causing postaxial or central polydactyly. This is distinct
from the preaxial polydactyly seen in GCPS, where GLI3 haploinsufficiency
(reduced activator) rather than constitutive repressor drives the phenotype.
biological_processes:
- preferred_term: Embryonic Limb Morphogenesis
term:
id: GO:0030326
label: embryonic limb morphogenesis
evidence:
- reference: PMID:10375510
reference_title: "Gli proteins encode context-dependent positive and negative functions: implications for development and disease."
supports: SUPPORT
snippet: "provide a molecular basis for the human Polydactyly type A and Pallister-Hall Syndrome phenotypes, derived from the deregulated production of C-terminally truncated GLI3 proteins"
explanation: "Truncated GLI3 directly causes the polydactyly phenotype in PHS."
- name: Hypothalamic-Pituitary Axis Disruption
description: >
The hypothalamic hamartoma disrupts normal hypothalamic-pituitary axis
signaling, producing a spectrum of endocrine insufficiency ranging from
isolated growth hormone deficiency to panhypopituitarism. Adrenal
insufficiency (secondary to ACTH deficiency) is a potentially lethal
complication in neonates and infants that requires urgent evaluation and
cortisol replacement before or alongside other endocrine workup. Precocious
puberty may result from ectopic GnRH secretion by the hamartoma.
biological_processes:
- preferred_term: Pituitary gland development
term:
id: GO:0021983
label: pituitary gland development
evidence:
- reference: PMID:20301638
reference_title: "GLI3-Related Pallister-Hall Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."
explanation: >-
GeneReviews explicitly documents pituitary insufficiency as a complication
and adrenal crisis as a potentially lethal outcome in untreated neonates.
phenotypes:
- name: Hypothalamic Hamartoma
description: >
Non-neoplastic malformation of the hypothalamus, often detected
on brain MRI. May cause precocious puberty through GnRH secretion
or gelastic seizures. A hallmark feature distinguishing PHS from
GCPS.
phenotype_term:
preferred_term: Hypothalamic hamartoma
term:
id: HP:0002444
label: Hypothalamic hamartoma
evidence:
- reference: PMID:24736735
reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
supports: SUPPORT
snippet: "PHS was first described as a lethal condition associating hypothalamic hamartoma, postaxial or central polydactyly, anal atresia and bifid epiglottis"
explanation: "Hypothalamic hamartoma is a cardinal feature of PHS since original description."
- name: Postaxial Polydactyly
description: >
Extra digits on the postaxial (ulnar/fibular) side, in contrast
to the preaxial polydactyly characteristic of GCPS. Central
polydactyly (insertional) may also occur.
phenotype_term:
preferred_term: Postaxial hand polydactyly
term:
id: HP:0001162
label: Postaxial hand polydactyly
evidence:
- reference: PMID:24736735
reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
supports: SUPPORT
snippet: "postaxial or central polydactyly, anal atresia and bifid epiglottis"
explanation: "Postaxial/central polydactyly is the characteristic limb pattern in PHS."
- reference: PMID:28224613
reference_title: "GLI3-related polydactyly: a review."
supports: SUPPORT
snippet: "four separate entities; each characterized by a specific pattern of polydactyly"
explanation: "PHS has a distinct polydactyly pattern (postaxial) from GCPS (preaxial)."
- name: Bifid Epiglottis
description: >
Midline cleft of the epiglottis, a distinctive feature of PHS.
Usually does not cause significant airway compromise but is
diagnostically important.
phenotype_term:
preferred_term: Bifid epiglottis
term:
id: HP:0010564
label: Bifid epiglottis
evidence:
- reference: PMID:24736735
reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
supports: SUPPORT
snippet: "hypothalamic hamartoma, postaxial or central polydactyly, anal atresia and bifid epiglottis"
explanation: "Bifid epiglottis is one of the cardinal features in the original PHS description."
- name: Anal Atresia
description: >
Imperforate anus, occurring in a significant proportion of PHS
patients. Requires surgical correction in the neonatal period.
phenotype_term:
preferred_term: Anal atresia
term:
id: HP:0002023
label: Anal atresia
evidence:
- reference: PMID:24736735
reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
supports: SUPPORT
snippet: "hypothalamic hamartoma, postaxial or central polydactyly, anal atresia and bifid epiglottis"
explanation: "Anal atresia is a cardinal feature of PHS."
- name: Central Precocious Puberty
description: >
Ectopic GnRH secretion from hypothalamic hamartoma can trigger premature
activation of the hypothalamic-pituitary-gonadal axis, causing central
precocious puberty. Annual surveillance during childhood monitors for
signs of early puberty onset.
phenotype_term:
preferred_term: Precocious puberty
term:
id: HP:0000826
label: Precocious puberty
evidence:
- reference: PMID:20301638
reference_title: "GLI3-Related Pallister-Hall Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "monitor for signs of precocious puberty"
explanation: >-
GeneReviews surveillance guidelines specify annual monitoring for precocious
puberty as a complication of hypothalamic hamartoma in GLI3-PHS.
- name: Gelastic Seizures
description: >
Hypothalamic hamartomas are associated with focal seizures, including
characteristic gelastic (laughing) seizures. Seizures may begin or worsen
with use of stimulants for ADHD. Symptomatic anti-seizure medication is
the primary management approach; surgical resection of the hamartoma is
generally contraindicated due to procedural risk.
phenotype_term:
preferred_term: Focal emotional seizure with laughing
term:
id: HP:0010821
label: Focal emotional seizure with laughing
evidence:
- reference: PMID:12773293
reference_title: "Epilepsy and hypothalamic hamartoma: look at the hand Pallister-Hall syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "who suffered from drug resistant laughing seizures since childhood"
explanation: >-
Case report of a PHS patient (postaxial polydactyly + hypothalamic hamartoma)
who presented with laughing seizures (gelastic seizures) since childhood,
directly linking this seizure type to PHS.
- reference: PMID:20301638
reference_title: "GLI3-Related Pallister-Hall Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "symptomatic treatment of seizures"
explanation: >-
GeneReviews lists seizures as a key manifestation requiring symptomatic
treatment in GLI3-PHS, associated with hypothalamic hamartoma.
- name: Hypopituitarism
description: >
Disruption of hypothalamic-pituitary signaling by the malformed
hypothalamic tissue can cause partial or complete anterior pituitary
insufficiency, including growth hormone deficiency and ACTH deficiency.
Pituitary function must be assessed in all newly diagnosed individuals.
phenotype_term:
preferred_term: Hypopituitarism
term:
id: HP:0040075
label: Hypopituitarism
evidence:
- reference: PMID:20301638
reference_title: "GLI3-Related Pallister-Hall Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."
explanation: >-
GeneReviews identifies pituitary insufficiency as an important complication
of GLI3-PHS that can be lethal if adrenal axis involvement is missed.
- name: Adrenal Insufficiency
description: >
Secondary (central) adrenal insufficiency from hypothalamic-pituitary
axis disruption. Cortisol deficiency requires urgent evaluation in all
newly diagnosed patients, particularly neonates and infants, where
undiagnosed adrenal crisis can be fatal. Treatment with cortisol
replacement must be initiated promptly.
phenotype_term:
preferred_term: Adrenal insufficiency
term:
id: HP:0000846
label: Adrenal insufficiency
evidence:
- reference: PMID:20301638
reference_title: "GLI3-Related Pallister-Hall Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency."
explanation: >-
GeneReviews documents adrenal insufficiency as a potentially lethal
complication requiring urgent evaluation and treatment.
- name: Laryngeal Cleft
description: >
At the severe end of the GLI3-PHS spectrum, laryngotracheal cleft can
cause respiratory compromise and neonatal lethality. Management depends
on the extent of the cleft and degree of respiratory impairment.
phenotype_term:
preferred_term: Laryngeal cleft
term:
id: HP:0008751
label: Laryngeal cleft
evidence:
- reference: PMID:20301638
reference_title: "GLI3-Related Pallister-Hall Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "laryngotracheal cleft with neonatal lethality at the severe end"
explanation: >-
GeneReviews defines the clinical spectrum of GLI3-PHS from mild
(polydactyly, bifid epiglottis) to lethal (laryngotracheal cleft).
genetic:
- name: GLI3 Mutations (Truncating, Middle Third)
association: Causative
notes: >
Frameshift and nonsense mutations in the middle third of GLI3
(ORF nt 1998-3481) on chromosome 7p14.1 specifically cause PHS.
These produce a truncated protein that functions as a constitutive
repressor of Hedgehog signaling targets. This is in contrast to
GCPS, where mutations throughout the gene cause haploinsufficiency.
The genotype-phenotype correlation is robust across multiple
large cohort studies.
Positional rule for disease classification: mutations in the first
third (nt 1-1997) or final third (nt 3482-end) of the ORF cause GCPS
only; mutations in the middle third (nt 1998-3481) cause PHS. An
important mechanistic requirement is that PHS-causing truncated proteins
must escape nonsense-mediated mRNA decay (NMD) to produce the constitutive
repressor. If NMD degrades the transcript, haploinsufficiency results and
the phenotype shifts toward GCPS. This NMD-escape requirement explains
why not all middle-third nonsense variants produce the PHS phenotype (e.g.,
c.2374C>T p.Arg792Ter maps to the middle-third position but causes GCPS).
Approximately 25% of individuals have a de novo pathogenic variant; de novo
cases tend to be more severely affected than those with an inherited variant.
evidence:
- reference: PMID:15739154
reference_title: "Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations."
supports: SUPPORT
snippet: "Mutations in the GLI3 zinc-finger transcription factor gene cause Greig cephalopolysyndactyly syndrome (GCPS) and Pallister-Hall syndrome (PHS), which are variable but distinct clinical entities"
explanation: "Establishes GLI3 as causative for both GCPS and PHS as allelic disorders."
- reference: PMID:15739154
reference_title: "Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: robust phenotype prediction from the type and position of GLI3 mutations."
supports: SUPPORT
snippet: "These results demonstrate a robust correlation of genotype and phenotype for GLI3 mutations and strongly support the hypothesis that these two allelic disorders have distinct modes of pathogenesis"
explanation: "Robust genotype-phenotype correlation across 135-patient cohort."
- reference: PMID:20672375
reference_title: "Molecular analysis expands the spectrum of phenotypes associated with GLI3 mutations."
supports: SUPPORT
snippet: "A range of phenotypes including Greig cephalopolysyndactyly and Pallister-Hall syndromes (GCPS, PHS) are caused by pathogenic mutation of the GLI3 gene"
explanation: "Expanded cohort confirms GLI3 as the causative gene for PHS."
- reference: PMID:24736735
reference_title: "New insights into genotype-phenotype correlation for GLI3 mutations."
supports: SUPPORT
snippet: "76 cases from 55 families with either a GLI3 mutation (49 GCPS and 21 PHS), or a large deletion encompassing the GLI3 gene (6 GCPS cases)"
explanation: "Additional large cohort confirming GLI3 genotype-phenotype correlations."
diagnosis:
- name: Clinical and Molecular Diagnosis
description: >-
GLI3-related Pallister-Hall syndrome is diagnosed clinically from the
combination of hypothalamic hamartoma and mesoaxial (central) polydactyly,
and is confirmed by identification of a heterozygous GLI3 pathogenic
variant on molecular genetic testing. Recognition matters because
hypothalamic hamartoma may cause hypopituitarism or gelastic seizures.
diagnosis_term:
preferred_term: molecular genetic testing
term:
id: NCIT:C19770
label: Molecular Analysis
evidence:
- reference: PMID:20301638
reference_title: "GLI3-Related Pallister-Hall Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The diagnosis of GLI3-PHS can be established in a proband with both hypothalamic hamartoma and mesoaxial polydactyly."
explanation: >-
GeneReviews defines the cardinal clinical diagnostic dyad for
GLI3-related Pallister-Hall syndrome.
treatments:
- name: Surgical Correction of Polydactyly
description: >
Surgical removal of extra digits in early childhood for
functional and cosmetic improvement.
therapeutic_modality: SURGERY
treatment_term:
preferred_term: surgical procedure
term:
id: NCIT:C15329
label: Surgical Procedure
located_in:
preferred_term: manus
term:
id: UBERON:0002398
label: manus
- name: Anal Atresia Repair
description: >
Neonatal surgical correction of imperforate anus, typically
posterior sagittal anorectoplasty (PSARP).
- name: Endocrine Management
description: >
Adrenal insufficiency is the first priority: cortisol deficiency must be
evaluated urgently in all newly diagnosed patients, especially neonates,
as untreated adrenal crisis can be fatal. Annual surveillance during
childhood includes growth assessment (for growth hormone deficiency) and
monitoring for signs of precocious puberty. GnRH analogs may be used if
central precocious puberty develops. Pituitary function testing should be
performed at baseline in all patients.
treatment_term:
preferred_term: endocrine hormone replacement and management
term:
id: NCIT:C15599
label: Hormone Replacement Therapy
evidence:
- reference: PMID:20301638
reference_title: "GLI3-Related Pallister-Hall Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Urgent treatment for endocrine abnormalities, especially cortisol deficiency"
explanation: >-
GeneReviews prioritizes cortisol deficiency treatment above other endocrine
management, emphasizing the lethal risk of undiagnosed adrenal insufficiency.
- name: Anti-Seizure Medication
description: >
Symptomatic treatment for seizures associated with hypothalamic hamartoma,
using standard anti-seizure medications. Stimulants prescribed for
ADHD may exacerbate seizures and should be used with caution or avoided.
treatment_term:
preferred_term: Anticonvulsant Therapy
term:
id: NCIT:C64172
label: Anticonvulsant Therapy
evidence:
- reference: PMID:20301638
reference_title: "GLI3-Related Pallister-Hall Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "symptomatic treatment of seizures"
explanation: >-
GeneReviews lists symptomatic seizure treatment as a key management step
and notes that stimulants may exacerbate seizures in GLI3-PHS.
- name: Hypothalamic Hamartoma — Watchful Waiting
description: >
Hypothalamic hamartomas in PHS are malformations, not neoplasms; they grow
at the same rate as surrounding brain tissue. Biopsy or surgical resection
is generally contraindicated because complications and the resulting need for
lifelong hormone replacement typically outweigh any potential benefit.
Management focuses on endocrine replacement and anti-seizure therapy rather
than surgical intervention.
treatment_term:
preferred_term: supportive care
term:
id: NCIT:C15747
label: Supportive Care
evidence:
- reference: PMID:20301638
reference_title: "GLI3-Related Pallister-Hall Syndrome."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Biopsy or resection of hypothalamic hamartoma may result in complications and lifelong need for hormone replacement."
explanation: >-
GeneReviews explicitly states that hamartoma biopsy or resection is
to be avoided in typical presentations of GLI3-PHS.
datasets: []
references:
- reference: PMID:20301638
title: "GLI3-Related Pallister-Hall Syndrome."
tags:
- GeneReviews
findings: []